Exhibit 99.1

Gentherm Reports 2020 Third Quarter Results

 

Record Quarterly Automotive Revenue

Achieved Highest Quarterly Gross Margin and Gross Margin Rate in Three Years

Strong Quarterly Net Income Growth and Record Quarterly Adjusted EBITDA

NORTHVILLE, Michigan, October 29, 2020 /Global Newswire/ - Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management technologies, today announced its financial results for the third quarter ended September 30, 2020.

Third Quarter Highlights

 

Product revenues of $259.5 million increased 8.1% from $240.1 million in the 2019 third quarter

 

Excluding the impact of foreign currency translation and divested assets, product revenues increased 8.1% year over year

 

GAAP diluted earnings per share was $0.73 as compared to $0.48 in the prior-year period

 

Adjusted earnings per share (see table herein) was $0.91 as compared to $0.68 in the prior-year period

 

Secured automotive new business awards totaling $80 million

 

Phil Eyler, the Company's President and CEO, said “I am pleased that the continued strong execution of our Focused Growth strategy has generated the highest quarterly revenue in two years and record quarterly operating income. In Automotive, we had a record revenue quarter and outperformed actual light vehicle production in our key markets by approximately 800 basis points. In Medical, we continued to deliver double-digit revenue growth.”

 

“The momentum on the topline along with our ongoing disciplined approach to managing expenses also enabled us to achieve the highest gross margin and gross margin rate in three years and record Adjusted EBITDA in the quarter. While there is still near-term uncertainty in the macroeconomic environment, I am proud of our global team for the fast response to OEM demand increases, our improving operating performance and expanding technology leadership. This, along with our strong balance sheet, gives us confidence in delivering long-term shareholder value,” continued Eyler.

 

2020 Third Quarter Financial Review

Product revenues of $259.5 million increased $19.5 million, or 8.1%, in the third quarter of 2020 as compared to the prior-year period. Excluding the impact of foreign currency translation, divested assets and assets held for sale, product revenues similarly increased 8.1% year over year.

 

Automotive revenues increased 9.4% year over year, as decreases in Automotive Cables and Other Automotive were more than offset by revenue increases in all other product categories. Adjusting for foreign currency translation, organic Automotive revenues increased 7.9% year over year. According to IHS Markit, actual light vehicle production was flat when compared to the third quarter of 2019 in the Company’s key markets of North America, Europe, China, Japan and Korea.  

 

The $2.0 million, or 17.2% revenue decrease in Industrial resulted from the divestiture of Global Power Technologies (“GPT”), which was sold on October 1, 2019. The decrease was partially offset by year-over-

 


 

year growth of 17.3% in Gentherm Medical, primarily due to increased demand for Stihler resistive blood warming products, Hemotherm® cardiovascular heater / cooler systems and the Blanketrol® solutions. 

 

See the “Revenue by Product Category” table included below for additional detail.

 

The gross margin rate increased to 31.8% in the current-year period versus 31.1% in the prior-year period, primarily as a result of higher labor productivity, fixed cost leverage from higher unit volume, supplier cost reductions and Fit-for-Growth cost reduction initiatives. These were partially offset by annual customer price reductions as well as wage inflation.

Net research and development expenses of $18.1 million in the third quarter of 2020 decreased $0.8 million, or 4.2%, year over year as a direct result of cost reduction initiatives partially offset by incentive compensation adjustments.  

Selling, general and administrative expenses of $25.8 million in the third quarter of 2020 decreased $1.1 million, or 4.1%, versus the prior-year period. The year-over-year improvement was primarily driven by the impact of cost reduction initiatives and the divestiture of the GPT business, partially offset by incentive compensation adjustments

Restructuring expenses for the third quarter of 2020 were $0.3 million, as compared to $8.7 million incurred in the prior-year period as a result of the restructuring plan to improve the Company’s manufacturing productivity and rationalize its footprint.  

As described more fully in the table included below, “Reconciliation of Net Income to Adjusted EBITDA,” the Company recorded Adjusted EBITDA of $50.1 million during the third quarter of 2020 compared to $40.7 million in the prior year, a year-over-year increase of $9.4 million or 23.1%.

Income tax expense in the 2020 third quarter was $9.6 million, as compared with $6.8 million in the prior-year period. The effective tax rate of 28.5% for the quarter differs from the U.S. Federal statutory rate of 21%, primarily due to higher tax rates in foreign tax jurisdictions.

GAAP diluted earnings per share for the third quarter of 2020 was $0.73 compared with $0.48 for the prior-year period. Adjusted diluted earnings per share, excluding restructuring expenses, impairment charges, unrealized currency gain, and other impacts (see table herein), was $0.91. Adjusted diluted earnings per share in the prior-year period was $0.68.

Guidance

As a result of the unprecedented uncertainty facing the automotive industry and global economy, Gentherm withdrew its 2020 full financial guidance on March 25, 2020 and has not been providing updates with the exception of commentary on revenue trends. The Company expects product revenues in the fourth quarter of 2020 to be in the range of $240 to $260 million. 

Conference Call

 

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13711413.

 

 


 

A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

 

A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on November 12, 2020. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13711413.

 

 

Investor Relations Contact
Yijing Brentano

investors@gentherm.com
(248) 308-1702

 

Media Contact

Melissa Fischer

media@gentherm.com

248.289.9702

 

About Gentherm

 

Gentherm (NASDAQ:THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery thermal management systems, cable systems and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 11,000 employees in facilities in the United States, Germany, Canada, China, Hungary, Japan, Korea, North Macedonia, Malta, Mexico, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com

 

Forward-Looking Statements 

 

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. Such statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including that: the COVID-19 pandemic and its direct and indirect adverse impacts on the automobile and medical industries and global economy has, and will continue to have, an adverse effect on, among other things, the Company’s results of operations, financial condition, cash flows, liquidity, business operations and stock price; future borrowing availability under the Company’s revolving credit facility is subject to compliance with covenants thereunder, and the deterioration of the Company’s financial performance during 2020 (including consolidated EBITDA) due to COVID-19 has caused the borrowing availability to be, and it may continue to be, substantially less than the full amount of

 


 

revolving credit facility; the Company’s failure to be in compliance with covenants under its debt agreements due to COVID-19 or otherwise could result in an event of default thereunder, and if the lenders thereunder do not agree to amend or waive, the amounts outstanding under its debt agreements may be accelerated and may become immediately due and payable; additional financing by accessing the capital markets may not be available on acceptable terms, if at all, and additional indebtedness may harm the Company’s financial position and impact the Company’s ability to comply with covenants under its debt agreements; the Company may not realize the expected benefits from any restructuring initiatives it may pursue as a result of the effects of COVID-19 or otherwise; declines in automobile production may have an adverse impact; sales may not increase and the projected future sales volumes on which the Company manages its business may be inaccurate; new business awards may be limited due to COVID-19 and related uncertainties, may not be converted into product revenues and our projections thereof are not updated after the date initially communicated to us by customers, including for the impact of COVID-19 on future business; new or improved competing products may be developed by competitors with greater resources; customer preferences may shift, including due to the evolving use of automobiles and technology; the Company may lose suppliers or customers; market acceptance of the Company’s existing or new products may decrease; currency exchange rates may change unfavorably; pricing pressures from customers may increase; the macroeconomic environment may present adverse conditions; new products may not be feasible; work stoppages impacting the Company, its suppliers or customers, due to labor matters, civil or political unrest, infectious diseases and epidemics or other reasons, could harm the Company’s operations; free trade agreements have recently been, and may in the future be, altered or additional tariffs may be implemented; customers may not accept pass-through of tariff costs; the Company may be unable to protect its intellectual property in certain jurisdictions; there may be manufacturing or design defects or other quality issues with the Company’s products; the Company may be unable to effectively implement ongoing restructuring and other cost-savings measures or realize the full amount of estimated savings; the Company’s business may be harmed by security breaches and other disruptions to its IT systems; the Company may be unable to comply with or may incur increased costs associated with complying with domestic and international regulations, which could change in an unfavorable manner; and other adverse conditions in the industries in which the Company operates may negatively affect its results. 

 

The foregoing risks should be read in conjunction with the Company's filings with the Securities and Exchange Commission (the “SEC”), including “Risk Factors”, in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, the business outlook discussed in this release does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s business and financial results. 

 

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. 

 

 


 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Product revenues

 

$

259,540

 

 

$

240,056

 

 

$

624,214

 

 

$

741,303

 

Cost of sales

 

 

176,935

 

 

 

165,364

 

 

 

448,807

 

 

 

518,590

 

Gross margin

 

 

82,605

 

 

 

74,692

 

 

 

175,407

 

 

 

222,713

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net research and development expenses

 

 

18,070

 

 

 

18,838

 

 

 

51,171

 

 

 

56,990

 

Selling, general and administrative expenses

 

 

25,745

 

 

 

26,861

 

 

 

73,474

 

 

 

91,683

 

Restructuring expenses

 

 

284

 

 

 

8,664

 

 

 

3,452

 

 

 

11,809

 

Total operating expenses

 

 

44,099

 

 

 

54,363

 

 

 

128,097

 

 

 

160,482

 

Operating income

 

 

38,506

 

 

 

20,329

 

 

 

47,310

 

 

 

62,231

 

Interest expense, net

 

 

(1,259

)

 

 

(1,148

)

 

 

(3,368

)

 

 

(3,756

)

Foreign currency (loss) gain

 

 

(2,883

)

 

 

4,083

 

 

 

(5,562

)

 

 

3,482

 

Gain on sale of business

 

 

 

 

 

 

 

 

 

 

 

4,970

 

Impairment loss

 

 

 

 

 

(837

)

 

 

 

 

 

(21,206

)

Other (loss) income

 

 

(615

)

 

 

231

 

 

 

2,531

 

 

 

545

 

Earnings before income tax

 

 

33,749

 

 

 

22,658

 

 

 

40,911

 

 

 

46,266

 

Income tax expense

 

 

9,603

 

 

 

6,771

 

 

 

15,214

 

 

 

19,214

 

Net income

 

$

24,146

 

 

$

15,887

 

 

$

25,697

 

 

$

27,052

 

Basic earnings per share

 

$

0.74

 

 

$

0.48

 

 

$

0.79

 

 

$

0.81

 

Diluted earnings per share

 

$

0.73

 

 

$

0.48

 

 

$

0.78

 

 

$

0.81

 

Weighted average number of shares – basic

 

 

32,624

 

 

 

32,839

 

 

 

32,631

 

 

 

33,283

 

Weighted average number of shares – diluted

 

 

32,958

 

 

 

32,933

 

 

 

32,924

 

 

 

33,419

 

 


 

GENTHERM INCORPORATED

REVENUE BY PRODUCT CATEGORY

(Unaudited, in thousands)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

% Change

 

 

2020

 

 

2019

 

 

% Change

 

Climate Control Seats (CCS)

 

$

97,058

 

 

$

88,133

 

 

 

10.1

%

 

$

229,465

 

 

$

270,924

 

 

 

(15.3

)%

Seat Heaters

 

 

73,471

 

 

 

71,030

 

 

 

3.4

%

 

 

171,345

 

 

 

218,578

 

 

 

(21.6

)%

Steering Wheel Heaters

 

 

22,506

 

 

 

16,621

 

 

 

35.4

%

 

 

49,721

 

 

 

49,620

 

 

 

0.2

%

Automotive Cables

 

 

18,917

 

 

 

20,361

 

 

 

(7.1

)%

 

 

50,890

 

 

 

66,316

 

 

 

(23.3

)%

Battery Thermal Management (BTM)

 

 

15,956

 

 

 

11,890

 

 

 

34.2

%

 

 

33,818

 

 

 

31,531

 

 

 

7.3

%

Electronics

 

 

14,463

 

 

 

11,729

 

 

 

23.3

%

 

 

38,327

 

 

 

36,035

 

 

 

6.4

%

Other Automotive

 

 

7,393

 

 

 

8,479

 

 

 

(12.8

)%

 

 

17,056

 

 

 

27,296

 

 

 

(37.5

)%

Subtotal Automotive

 

 

249,764

 

 

 

228,243

 

 

 

9.4

%

 

 

590,622

 

 

 

700,300

 

 

 

(15.7

)%

Medical

 

 

9,776

 

 

 

8,336

 

 

 

17.3

%

 

 

33,592

 

 

 

26,404

 

 

 

27.2

%

GPT

 

 

 

 

 

3,477

 

 

 

(100.0

)%

 

 

 

 

 

11,181

 

 

 

(100.0

)%

CSZ-IC

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,418

 

 

 

(100.0

)%

Subtotal Industrial

 

 

9,776

 

 

 

11,813

 

 

 

(17.2

)%

 

 

33,592

 

 

 

41,003

 

 

 

(18.1

)%

Total Company

 

 

259,540

 

 

 

240,056

 

 

 

8.1

%

 

 

624,214

 

 

 

741,303

 

 

 

(15.8

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Core Businesses (Automotive and Medical)

 

$

259,540

 

 

$

236,579

 

 

 

9.7

%

 

$

624,214

 

 

$

726,704

 

 

 

(14.1

)%

 

 


 

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net income

 

$

24,146

 

 

$

15,887

 

 

$

25,697

 

 

$

27,052

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

9,603

 

 

 

6,771

 

 

 

15,214

 

 

 

19,214

 

Interest expense

 

 

1,259

 

 

 

1,148

 

 

 

3,368

 

 

 

3,756

 

Depreciation and amortization

 

 

10,129

 

 

 

10,974

 

 

 

30,129

 

 

 

33,048

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring expense

 

 

284

 

 

 

8,664

 

 

 

3,452

 

 

 

11,809

 

Impairment loss

 

 

 

 

 

837

 

 

 

 

 

 

21,206

 

Gain on sale of business

 

 

 

 

 

 

 

 

 

 

 

(4,970

)

Acquisition and divestiture expenses

 

 

608

 

 

 

19

 

 

 

608

 

 

 

399

 

Unrealized currency loss (gain)

 

 

4,117

 

 

 

(3,564

)

 

 

6,491

 

 

 

(4,487

)

Gain on sale of patents

 

 

 

 

 

 

 

 

(1,978

)

 

 

 

CFO transition expenses

 

 

 

 

 

 

 

 

 

 

 

1,065

 

Adjusted EBITDA

 

$

50,146

 

 

$

40,736

 

 

$

82,981

 

 

$

108,092

 

 

Use of Non-GAAP Financial Measures

 

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided information regarding adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) and adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”), each, a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company’s reconciliation of net income to Adjusted EBITDA is provided in this release. The Company’s Reconciliation of Adjusted EPS can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated October 29, 2020 and also is included in the presentation entitled “Q3 2020 Gentherm Incorporated Earnings Conference Presentation,” which can be found on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

 

In evaluating its business, the Company considers and uses Adjusted EBITDA and Adjusted EPS as supplemental measures of its operating performance. Management provides Adjusted EBITDA and Adjusted EPS measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA or Adjusted EPS in isolation, or as a substitute for net income or other consolidated income statement data prepared in accordance with GAAP.

 

Non-GAAP measures referenced in this release may include estimates of future Adjusted EBITDA and Adjusted EPS. Such forward-looking non-GAAP measures may differ significantly from the corresponding GAAP measures, due to

 


 

depreciation and amortization, tax expense, and/or interest expense, some or all of which management has not quantified for the future periods.

 


 

GENTHERM INCORPORATED

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

(In thousands, except per share data)

(Unaudited)

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

Sept 30,

 

 

Sept 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net income

 

$

24,146

 

 

$

15,887

 

 

$

25,697

 

 

$

27,052

 

Restructuring expenses

 

 

284

 

 

 

8,664

 

 

 

3,452

 

 

 

11,809

 

Gain on sale of business

 

 

 

 

 

 

 

 

 

 

 

(4,970

)

Gain on sale of patents

 

 

 

 

 

 

 

 

(1,978

)

 

 

 

Impairment loss

 

 

 

 

 

837

 

 

 

 

 

 

21,206

 

Unrealized currency loss (gain)

 

 

4,117

 

 

 

(3,564

)

 

 

6,491

 

 

 

(4,487

)

CFO transition

 

 

 

 

 

 

 

 

 

 

 

1,065

 

Acquisition and divestiture expenses

 

 

608

 

 

 

19

 

 

 

608

 

 

 

399

 

Non-cash purchase accounting impact

 

 

2,259

 

 

 

2,556

 

 

 

6,543

 

 

 

7,456

 

Tax effect of above

 

 

(1,435

)

 

 

(2,059

)

 

 

(3,764

)

 

 

(2,964

)

Adjusted net income

 

$

29,979

 

 

$

22,340

 

 

$

37,049

 

 

$

56,566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

32,623,532

 

 

 

32,838,636

 

 

 

32,631,423

 

 

 

33,282,584

 

Diluted

 

 

32,958,439

 

 

 

32,932,679

 

 

 

32,924,013

 

 

 

33,418,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share, as reported:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.74

 

 

$

0.48

 

 

$

0.79

 

 

$

0.81

 

Diluted

 

$

0.73

 

 

$

0.48

 

 

$

0.78

 

 

$

0.81

 

Adjusted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.92

 

 

$

0.68

 

 

$

1.14

 

 

$

1.70

 

Diluted

 

$

0.91

 

 

$

0.68

 

 

$

1.13

 

 

$

1.69

 


 


 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 

 

 

September 30, 2020

 

 

December 31, 2019

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

226,533

 

 

$

50,443

 

Restricted cash

 

 

2,506

 

 

 

2,505

 

Accounts receivable, net

 

 

193,249

 

 

 

159,710

 

Inventory:

 

 

 

 

 

 

 

 

Raw materials

 

 

62,970

 

 

 

61,323

 

Work in process

 

 

7,708

 

 

 

7,444

 

Finished goods

 

 

43,958

 

 

 

49,712

 

Inventory, net

 

 

114,636

 

 

 

118,479

 

Other current assets

 

 

37,988

 

 

 

42,726

 

Total current assets

 

 

574,912

 

 

 

373,863

 

Property and equipment, net

 

 

150,801

 

 

 

160,605

 

Goodwill

 

 

66,266

 

 

 

64,572

 

Other intangible assets, net

 

 

47,429

 

 

 

49,783

 

Operating lease right-of-use assets

 

 

18,844

 

 

 

11,587

 

Deferred income tax assets

 

 

55,641

 

 

 

57,650

 

Other non-current assets

 

 

7,554

 

 

 

9,326

 

Total assets

 

$

921,447

 

 

$

727,386

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

108,452

 

 

$

83,035

 

Current lease liabilities

 

 

5,206

 

 

 

4,586

 

Current maturities of long-term debt

 

 

2,500

 

 

 

2,500

 

Other current liabilities

 

 

74,443

 

 

 

66,583

 

Total current liabilities

 

 

190,601

 

 

 

156,704

 

Long-term debt, less current maturities

 

 

193,061

 

 

 

78,124

 

Non-current lease liabilities

 

 

15,046

 

 

 

6,751

 

Pension benefit obligation

 

 

7,864

 

 

 

8,057

 

Other non-current liabilities

 

 

3,079

 

 

 

5,100

 

Total liabilities

 

$

409,651

 

 

$

254,736

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Common Stock:

 

 

 

 

 

 

 

 

No par value; 55,000,000 shares authorized 32,680,013 and 32,674,354 issued and outstanding at September 30, 2020 and December 31, 2019, respectively

 

 

107,055

 

 

 

102,507

 

Paid-in capital

 

 

9,798

 

 

 

10,852

 

Accumulated other comprehensive loss

 

 

(32,486

)

 

 

(42,441

)

Accumulated earnings

 

 

427,429

 

 

 

401,732

 

Total shareholders’ equity

 

 

511,796

 

 

 

472,650

 

Total liabilities and shareholders’ equity

 

$

921,447

 

 

$

727,386

 

 


 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

Operating Activities:

 

 

 

 

 

 

 

 

Net income

 

$

25,697

 

 

$

27,052

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

30,777

 

 

 

33,281

 

Deferred income taxes

 

 

3,583

 

 

 

5,072

 

Non-cash stock based compensation

 

 

6,569

 

 

 

5,268

 

Defined benefit plan income

 

 

(433

)

 

 

(754

)

Loss on sale of property and equipment

 

 

562

 

 

 

319

 

Operating lease expense

 

 

5,156

 

 

 

4,477

 

Gain on sale of patents

 

 

(1,978

)

 

 

 

Impairment loss

 

 

 

 

 

21,206

 

Gain on sale of business

 

 

 

 

 

(4,970

)

Other

 

 

 

 

 

189

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(33,250

)

 

 

(5,961

)

Inventory

 

 

4,645

 

 

 

(5,512

)

Other assets

 

 

(4,655

)

 

 

9,594

 

Accounts payable

 

 

24,272

 

 

 

(3,097

)

Other liabilities

 

 

12,356

 

 

 

(2,172

)

Net cash provided by operating activities

 

 

73,301

 

 

 

83,992

 

Investing Activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(11,613

)

 

 

(18,340

)

Acquisition of intangible assets

 

 

(3,141

)

 

 

 

Proceeds from the sale of patents and property and equipment

 

 

1,068

 

 

 

137

 

Proceeds from divestiture of business

 

 

 

 

 

47,500

 

Acquisition of subsidiary, net of cash acquired

 

 

 

 

 

(14,823

)

Net cash (used in) provided by investing activities

 

 

(13,686

)

 

 

14,474

 

Financing Activities:

 

 

 

 

 

 

 

 

Borrowing of debt

 

 

201,193

 

 

 

29,470

 

Repayments of debt

 

 

(87,688

)

 

 

(69,049

)

Cash paid for the repurchase of Common Stock

 

 

(9,092

)

 

 

(58,040

)

Proceeds from the exercise of Common Stock options

 

 

6,828

 

 

 

13,879

 

Cash paid for the cancellation of restricted stock

 

 

(811

)

 

 

(1,213

)

Acquisition contingent consideration payment

 

 

(618

)

 

 

 

Cash paid for financing costs

 

 

 

 

 

(1,278

)

Net cash provided by (used in) financing activities

 

 

109,812

 

 

 

(86,231

)

Foreign currency effect

 

 

6,664

 

 

 

(4,151

)

Net increase in cash, cash equivalents and restricted cash

 

 

176,091

 

 

 

8,084

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

52,948

 

 

 

39,620

 

Cash, cash equivalents and restricted cash at end of period

 

$

229,039

 

 

$

47,704

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Cash (refund) paid for taxes

 

$

(252

)

 

$

6,676

 

Cash paid for interest

 

$

3,006

 

 

$

3,437

 

 

 

 


 

####

 

View differences made from one to another to evaluate Gentherm Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gentherm Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account